- Home
- IVA vs NATH Comparison
IVA vs NATH Comparison
Compare IVA & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- NATH
- Stock Information
- Founded
- IVA 2011
- NATH 1916
- Country
- IVA France
- NATH United States
- Employees
- IVA N/A
- NATH N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- IVA Health Care
- NATH Consumer Discretionary
- Exchange
- IVA Nasdaq
- NATH Nasdaq
- Market Cap
- IVA 359.6M
- NATH 385.4M
- IPO Year
- IVA 2020
- NATH N/A
- Fundamental
- Price
- IVA $3.62
- NATH $105.19
- Analyst Decision
- IVA Strong Buy
- NATH
- Analyst Count
- IVA 4
- NATH 0
- Target Price
- IVA $10.50
- NATH N/A
- AVG Volume (30 Days)
- IVA 22.8K
- NATH 23.7K
- Earning Date
- IVA 03-26-2025
- NATH 06-11-2025
- Dividend Yield
- IVA N/A
- NATH 1.90%
- EPS Growth
- IVA N/A
- NATH 24.88
- EPS
- IVA N/A
- NATH 5.80
- Revenue
- IVA $14,591,573.00
- NATH $146,386,000.00
- Revenue This Year
- IVA $15.38
- NATH N/A
- Revenue Next Year
- IVA $24.22
- NATH N/A
- P/E Ratio
- IVA N/A
- NATH $17.96
- Revenue Growth
- IVA N/A
- NATH 6.83
- 52 Week Low
- IVA $1.53
- NATH $66.35
- 52 Week High
- IVA $4.05
- NATH $107.00
- Technical
- Relative Strength Index (RSI)
- IVA 58.88
- NATH 59.31
- Support Level
- IVA $3.13
- NATH $100.90
- Resistance Level
- IVA $3.54
- NATH $107.00
- Average True Range (ATR)
- IVA 0.27
- NATH 3.01
- MACD
- IVA 0.02
- NATH 0.00
- Stochastic Oscillator
- IVA 69.66
- NATH 74.72
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.